Literature DB >> 11177451

Injecting drug users' adherence to HIV antiretroviral treatments: physicians' beliefs.

N Escaffre1, M Morin, A D Bouhnik, J G Fuzibet, J A Gastaut, Y Obadia, J P Moatti.   

Abstract

This paper investigates physicians' judgements about adherence to antiretroviral treatment (ART) among patients who have been HIV-infected through injecting drug use (IDU). Comparisons were made between data collected from physicians at enrollment (January 1996 to January 1998) of a prospective cohort study (MANIF 2000) and self-declarations of 196 HIV-infected injecting drug users (IDUs) who have been prescribed ART. The likelihood of being perceived as 'adherent' by physicians was higher for women, patients of 30 years of age or older, with biological markers indicative of a healthier status, and who were perceived as 'free of injecting behaviour' and not in drug maintenance treatment. Although the proportion of non-adherent patients was similar in physicians' assessment (26.0%) and patients' self-declarations (27.0%), a strong discordance occurred: 60.4% of patients self-reporting non-adherence to ART (80.0% for those receiving a protease inhibitor) were classified as adherent by their prescribing physicians. The study suggests that a priori judgements based on clinical experience but also on social stereotypes interfere with physicians' assessment, and that physicians' decisions to initiate complex treatment regimens may further induce optimistic biases and an underestimation of the problems faced by IDU patients to adequately adhere to them.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11177451     DOI: 10.1080/09540120020014264

Source DB:  PubMed          Journal:  AIDS Care        ISSN: 0954-0121


  11 in total

1.  Case files from the Bellevue Hospital Center at New York University--lipoatrophy following long-term antiretroviral therapy.

Authors:  Demetre Daskalakis; Judith A Aberg
Journal:  MedGenMed       Date:  2005-10-11

2.  No variability across centers in adherence and response to HAART in French hospitals: results from the ANRS-EN12-VESPA study.

Authors:  Rémi Sitta; France Lert; Alice Gueguen; Bruno Spire; Rosemary Dray-Spira
Journal:  J Acquir Immune Defic Syndr       Date:  2009-12       Impact factor: 3.731

3.  Patient-reported and physician-estimated adherence to HAART: social and clinic center-related factors are associated with discordance.

Authors:  Rita Murri; Adriana Ammassari; Maria Paola Trotta; Andrea De Luca; Sara Melzi; Cristina Minardi; Mauro Zaccarelli; Patrizia Rellecati; Paola Santopadre; Fabrizio Soscia; Antonio Scasso; Valerio Tozzi; Maria Ciardi; Gian Carlo Orofino; Pasquale Noto; Antonella d'Arminio Monforte; Andrea Antinori; Albert W Wu
Journal:  J Gen Intern Med       Date:  2004-11       Impact factor: 5.128

4.  Barriers to antiretroviral treatment access for injecting drug users living with HIV in Chennai, South India.

Authors:  Venkatesan Chakrapani; Jaikumar Velayudham; Murali Shunmugam; Peter A Newman; Robert Dubrow
Journal:  AIDS Care       Date:  2013-11-28

Review 5.  Heart failure in patients with human immunodeficiency virus infection: epidemiology, pathophysiology, treatment, and future research.

Authors:  Joshua Remick; Vasiliki Georgiopoulou; Catherine Marti; Igho Ofotokun; Andreas Kalogeropoulos; William Lewis; Javed Butler
Journal:  Circulation       Date:  2014-04-29       Impact factor: 29.690

6.  The effects of enhanced access to antiretroviral therapy: a qualitative study of community perceptions in Kampala city, Uganda.

Authors:  Lynn Atuyambe; Stella Neema; Erasmus Otolok-Tanga; Gakenia Wamuyu-Maina; Simon Kasasa; Fred Wabwire-Mangen
Journal:  Afr Health Sci       Date:  2008-03       Impact factor: 0.927

7.  Disparities in HIV treatment and physician attitudes about delaying protease inhibitors for nonadherent patients.

Authors:  Mitchell D Wong; William E Cunningham; Martin F Shapiro; Ronald M Andersen; Paul D Cleary; Naihua Duan; Hong Hu Liu; Ira B Wilson; Bruce E Landon; Neil S Wenger
Journal:  J Gen Intern Med       Date:  2004-04       Impact factor: 5.128

8.  Physician experience and rates of plasma HIV-1 RNA suppression among illicit drug users: an observational study.

Authors:  Sassan Sangsari; M-J Milloy; Amir Ibrahim; Thomas Kerr; Ruth Zhang; Julio Montaner; Evan Wood
Journal:  BMC Infect Dis       Date:  2012-01-25       Impact factor: 3.090

9.  Task shifting redefined: removing social and structural barriers to improve delivery of HIV services for people who inject drugs.

Authors:  Lianping Ti; Thomas Kerr
Journal:  Harm Reduct J       Date:  2013-10-04

10.  Plasma HIV-1 RNA viral load rebound among people who inject drugs receiving antiretroviral therapy (ART) in a Canadian setting: an ethno-epidemiological study.

Authors:  Will Small; M J Milloy; Ryan McNeil; Lisa Maher; Thomas Kerr
Journal:  AIDS Res Ther       Date:  2016-07-25       Impact factor: 2.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.